Variations in patient-reported physical health between cardiac and musculoskeletal diseases: systematic review and meta-analysis of population-based studies

Health and Quality of Life Outcomes

Umesh T. Kadam²  Kelvin P. Jordan¹  James A. Prior¹ 

[1] Research Institute for Primary Care and Health Sciences, Keele University, Staffordshire ST5 5BG, UK;Health Services Research Unit, Keele University, Keele, UK

关键词: Quality-of-Life;    Physical health;    Musculoskeletal diseases;    Chronic Disease;    Cardiovascular diseases;   

Others  :  1209228
DOI  :  10.1186/s12955-015-0265-x

 received in 2015-01-16, accepted in 2015-05-15,  发布年份 2015

【 摘 要 】

Population-based assessments of physical health are important to evaluate healthcare resource allocation. Normative data on the level of physical impairments attributable to specific diseases and severity levels within these diseases is critical to interpreting such data. Our objective, by means of a systematic review and meta-analysis, was to test the hypothesis that specific diseases which form cardiovascular and musculoskeletal disease spectra are associated with gradients of physical impairments. We examined a cardiovascular disease spectrum which consisted of hypertension, ischaemic heart disease and heart failure, and a musculoskeletal disease spectrum of lower back pain, osteoarthritis and rheumatoid arthritis. Using Medline, EMBASE and CINAHL databases, articles which had examined these morbidities and used either the SF-12 or SF-36 in general or primary care populations were selected; data was extracted independently by three reviewers. Study characteristics were described and the mean physical component summary scores of the SF-12 or SF-36 was analysed by disease, using random-effects meta-analysis. The association between disease and physical health (mean physical component summary scores) was assessed using multilevel meta-regression analysis, adjusting for age, health setting, country, disease definition and SF-12 or 36 format. From this search, 26 articles were identified, yielding 70 separate estimates of mean physical component summary scores across the morbidities from 14 different countries. For the selected conditions, pooled unadjusted mean physical component summary scores were: 44.4 for hypertension, 38.9 for ischaemic heart disease, 35.9 for heart failure, 39.5 for lower back pain, 36.0 for osteoarthritis and 36.5 for rheumatoid arthritis. The adjusted meta-regression showed mean physical component summary score difference for ischaemic heart disease of −4.6 (95 % confidence interval −6.0 to −3.2) and heart failure −7.5 (−9.1 to −5.9) compared to the hypertension category. For osteoarthritis −4.2 (−5.3 to −3.0) and rheumatoid arthritis −3.9 (−9.5 to 1.6) compared to the lower back pain category. Our findings provide the benchmark norms for the differences in physical health within and between disease spectra. Improved characterisation of the relative impact of individual conditions on physical health will facilitate public health assessments of chronic diseases as well as assessments of interventions using functional patient-reported outcomes.

【 授权许可】

   
2015 Prior et al.; licensee BioMed Central.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】

• [1]Sprangers MAG, de Regt EB, Andries F, van Agt HME, Bijl RV, de Boer JB et al.. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000; 53(9):895-907.
• [2]Bayliss M, Rendas-Baum R, White M, Maruish M, Bjorner J, Tunis S. Health-related quality of life (HRQL) for individuals with self-reported chronic physical and/or mental health conditions: panel survey of an adult sample in the United States. HQLO. 2012; 10(1):154.
• [3]Loza E, Lopez-Gomez JM, Abasolo L, Maese J, Carmona L, Batlle-Gualda E et al.. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum. 2009; 61(2):158-65.
• [4]Cunillera O, Tresserras R, Rajmil L, Vilagut G, Brugulat P, Herdman M et al.. Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey. Qual Life Res. 2010; 19(6):853-64.
• [5]Bardage C, Isacson DG. Hypertension and health-related quality of life. an epidemiological study in Sweden. J Clin Epidemiol. 2001; 54(2):172-81.
• [6]Jordan KP, Jöud A, Bergknut C, Croft P, Edwards JJ, Peat G, Petersson IF, Turkiewicz A, Wilkie R, Englund M: International comparisons of the consultation prevalence of musculoskeletal conditions using population-based healthcare data from England and Sweden. Ann Rheum Dis. 2014;73(1):212-8.
• [7]Kadam UT, Jordan K, Croft PR. A comparison of two consensus methods for classifying morbidities in a single professional group showed the same outcomes. J Clin Epidemiol. 2006; 59(0895–4356; 11):1169-73.
• [8]Kadam UT, Schellevis FG, van der Windt DA, de Vet HC, Bouter LM, Croft PR. Morbidity severity classifying routine consultations from English and Dutch general practice indicated physical health status. J Clin Epidemiol. 2008; 61(4):386-93.
• [9]Kadam UT, Schellevis FG, Lewis M, van der Windt DA, de Vet HC, Bouter LM et al.. Does age modify the relationship between morbidity severity and physical health in English and Dutch family practice populations? Qual Life Res. 2009; 18(2):209-20.
• [10]Prior JA, Kadam UT. Cardiovascular disease and musculoskeletal disorder labels in family practice acted as markers of physical health severity. J Clin Epidemiol. 2011; 64(5):547-55.
• [11]Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002; 324(7351):1417.
• [12]Levy D, Larson MG, Vasan RS, Kannel WB,Ho KK. The Progression From Hypertension to Congestive Heart Failure. JAMA. 1996;275(20):1557-1562. doi:10.1001/jama.1996.03530440037034
• [13]Woolf AD, Åkesson K. Can we reduce the burden of musculoskeletal conditions? The European action towards better musculoskeletal health. Best Pract Res Cl Rh. 2007; 21(1):1-3.
• [14]Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-83.
• [15]Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3):220-33.
• [16]Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care. 1995; 33(4 Suppl):AS264-79.
• [17]Cote I, Gregoire JP, Moisan J, Chabot I. Quality of life in hypertension: the SF-12 compared to the SF-36. Can J Clin Pharmacol. 2004; 11(2):e232-8.
• [18]Jenkinson CRIS, Jenkinson DAMI, Shepperd SASH, Richard LAYT, Petersen SOPH. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing. 1997; 26(1):7-13.
• [19]Mols F, Pelle AJ, Kupper N. Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population. Qual Life Res. 2009; 18(4):403-14.
• [20]Gandhi SK, Salmon JW, Zhao SZ, Lambert BL, Gore PR, Conrad K. Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials. Clin Ther. 2001; 23(7):1080-98.
• [21]Goldstein H, Yang M, Omar R, Turner R, Thompson S. Meta-analysis using multilevel models with an application to the study of class size effects. J R Stat Soc: Ser C: Appl Stat. 2000; 49(3):399-412.
• [22]Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the health utilities index mark II. Pharmacoeconomics. 1999; 15(2):141-55.
• [23]Rasbash J, Steele F, Browne WJ, Goldstein H: A user’s guide to MLwiN version 2.0. Printed in the United Kingdom: University of Bristol; 2005.
• [24]Johnson JA, Pickard AS. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care. 2000; 38(1):115-21.
• [25]Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a User’s manual. The Health Institute, Boston, MA; 1994.
• [26]Erickson SR, Williams BC, Gruppen LD. Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Hum Hypertens. 2001; 15(8):539-48.
• [27]Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 2002; 23(23):1867-76.
• [28]Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F, Carretero-Ares JL, Arzua-Mouronte D, Herreros-Fernandez V. Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens. 2003; 21(7):1283-9.
• [29]Lam CLK, Tse EYY, Gandek B, Fong DYT. The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population. J Clin Epidemiol. 2005; 58(8):815-22.
• [30]Schmidt AC, Bramlage P, Limberg R, Kreutz R. Quality of life in hypertension management using olmesartan in primary care. Expert Opin Pharmacother. 2008; 9(10):1641-53.
• [31]Wang HM, Beyer M, Gensichen J, Gerlach FM. Health-related quality of life among general practice patients with differing chronic diseases in Germany: cross sectional survey. BMC Public Health. 2008; 8(1471–2458):246. BioMed Central Full Text
• [32]Quercioli C, Messina G, Barbini E, Carriero G, Fani M, Nante N. Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performances of three tools: comparison of three questionnaire scores. J Health Econ. 2009; 10(4):389-97.
• [33]Grimaldi-Bensouda L, Begaud B, Lert F, Rouillon F, Massol J, Guillemot D et al.. Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practices. BMJ Open. 2011; 1(2):e000215.
• [34]de la Hoz Caballer B, Rodriguez M, Fraj J, Cerecedo I, Antolin-Amerigo D, Colas C. Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the cross-sectional study to evAluate work productivity in allergic rhinitis compared with other common dIseases (CAPRI) study. Am J Rhinol Allergy. 2012; 26(5):390-4.
• [35]Zygmuntowicz M, Owczarek A, Elibol A, Chudek J. Comorbidities and the quality of life in hypertensive patients. Pol Arch Med Wewn. 2012; 122(7–8):333-40.
• [36]Alonso J, Ferrer M, Gandek B, Ware JE, Aaronson NK, Mosconi P et al.. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) project. Qual Life Res. 2004; 13(2):283-98.
• [37]Buckley B, Murphy AW. Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study. Heart. 2009; 95(6):461-7.
• [38]Sidorov J, Shull RD, Girolami S, Mensch D. Use of the short form 36 in a primary care based disease management program for patients with congestive heart failure. Dis Manag. 2003; 6(2):111-7.
• [39]Faller H, Stork S, Schowalter M, Steinbuchel T, Wollner V, Ertl G et al.. Is health-related quality of life an independent predictor of survival in patients with chronic heart failure? J Psychosom Res. 2007; 63(5):533-8.
• [40]Suarez-Almazor ME, Kendall C, Johnson JA, Skeith K, Vincent D. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments. Rheumatology. 2000; 39(7):783-90.
• [41]Salaffi F, De Angelis R, Stancati A, Grassi W, Pain M, Prevalence IG. Health-related quality of life in multiple musculoskeletal conditions: a cross-sectional population based epidemiological study. II. The MAPPING study. Clin Experimental Rheumatol. 2005; 23(6):829-39.
• [42]Hicks GE, Gaines JM, Shardell M, Simonsick EM. Associations of back and leg pain with health status and functional capacity of older adults: findings from the retirement community back pain study. Arthritis Rheum. 2008; 59(9):1306-13.
• [43]Rannou F, Boutron I, Jardinaud-Lopez M, Meric G, Revel M, Fermanian J et al.. Should aggregate scores of the medical outcomes study 36-item short form health survey be used to assess quality of life in knee and hip osteoarthritis? a national survey in primary care. Osteoarthritis Cartilage. 2007; 15(9):1013-8.
• [44]Kahn KL, MacLean CH, Liu H, Rubenstein LZ, Wong AL, Harker JO et al.. The complexity of care for patients with rheumatoid arthritis: metrics for better understanding chronic disease care. Med Care. 2007; 45(1):55-65.
• [45]Uhlig T, Loge JH, Kristiansen IS, Kvien TK. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2007; 34(6):1241-7.
• [46]Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol. 2009; 27(5):S67-74.
• [47]Ware Jr JE, Kosinski M, Turner-Bowker DM, Gandek B. User’s Manual for the SF-12v2® Health Survey With a Supplement Documenting SF-12® Health Survey) Lincoln, RI: QualityMetric Incorporated, 2002.
• [48]Frendl DM, Ware JE. Patient-reported functional health and well-being outcomes with drug therapy: a systematic review of randomized trials using the SF-36 health survey. Med Care. 2014; 52(5):439-45.
• [49]Barton P, Andronis L, Briggs A, McPherson K, Capewell S. Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ. 2011; 343:d4044.
• [50]Ahern R, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray C. Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr. 2011; 9(1):8. BioMed Central Full Text
• [51]Morone NE, Karp JF, Lynch CS, Bost JE, El Khoudary SR, Weiner DK. Impact of chronic musculoskeletal pathology on older adults: a study of differences between knee OA and low back pain. Pain Med. 2009; 10(4):693-701.
• [52]Huijnen IPJ, Verbunt JA, Peters ML, Delespaul P, Kindermans HPJ, Roelofs J et al.. Do depression and pain intensity interfere with physical activity in daily life in patients with chronic low back pain? Pain. 2010; 150(1):161-6.
• [53]Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011; 13(6):513-20.
• [54]McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al.. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2012; 14(8):803-69.
• [55]Qaseem A, Fihn SD, Williams S, Dallas P, Owens DK, Shekelle P et al.. Diagnosis of stable ischemic heart disease: summary of a clinical practice guideline from the American college of physicians/american college of cardiology foundation/american heart association/american association for thoracic surgery/preventive cardiovascular nurses association/society of thoracic surgeons. Ann Intern Med. 2012; 157(10):729-34.
• [56]Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B et al.. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2010; 69(3):483-9.
• [57]Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO et al.. Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9):2569-81.